CIK 0000014272
- Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 220790350
- Phone
- +1 609-252-4621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-30 | Hidalgo Medina Manuel Director | Grant or award · Deferred Share Units | +121.47 | 2,116.25 | ||
| 2021-09-30 | Price Paula A Director | Grant or award · Deferred Share Units | +137.32 | 4,972.68 | ||
| 2021-09-30 | Rice Derica W Director | Grant or award · Deferred Share Units | +591.52 | 6,618.06 | ||
| 2021-09-30 | Samuels Theodore R. II Director | Grant or award · Deferred Share Units | +802.77 | 26,969.24 | ||
| 2021-09-30 | Storch Gerald L Director | Grant or award · Deferred Share Units | +591.52 | 65,780.26 | ||
| 2021-09-30 | YALE PHYLLIS R Director | Grant or award · Deferred Share Units | +549.27 | 10,622.08 | ||
| 2021-09-20 | Caforio Giovanni Board Chair and CEO | Sale | −25,000 | $60.64 | $1.5M | 483,980.33 |
| 2021-08-12 | Elkins David V EVP, Chief Financial Officer | Sale | −40,000 | $66.88 | $2.7M | 69,699 |
| 2021-08-12 | Elkins David V EVP, Chief Financial Officer | Option exercise | +6,180 | $48.49 | $300K | 75,879 |
| 2021-08-12 | Elkins David V EVP, Chief Financial Officer | Option exercise | +4,129 | $48.49 | $200K | 80,008 |
| 2021-08-12 | Elkins David V EVP, Chief Financial Officer | Option exercise | +59,691 | $48.49 | $2.9M | 139,699 |
| 2021-08-12 | Elkins David V EVP, Chief Financial Officer | Sale | −59,691 | $67.00 | $4.0M | 80,008 |
| 2021-08-12 | Elkins David V EVP, Chief Financial Officer | Option exercise · Option (right to buy) | −6,180 | 2,063 | ||
| 2021-08-12 | Elkins David V EVP, Chief Financial Officer | Option exercise · Option (right to buy) | −4,129 | 121,214 | ||
| 2021-08-12 | Elkins David V EVP, Chief Financial Officer | Option exercise · Option (right to buy) | −59,691 | 0 | ||
| 2021-08-03 | Powell Ann EVP, Chief Human Resources | Sale | −23,280 | $68.57 | $1.6M | 47,613.09 |
| 2021-08-02 | Caforio Giovanni Chairman and CEO | Sale | −20,000 | $68.58 | $1.4M | 508,980.33 |
| 2021-08-01 | Elkins David V EVP, Chief Financial Officer | Option exercise | +46,403 | 133,435 | ||
| 2021-08-01 | Elkins David V EVP, Chief Financial Officer | Shares withheld for taxes | −23,736 | $67.87 | $1.6M | 109,699 |
| 2021-08-01 | Elkins David V EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −46,403 | 0 |
Page 68 of 73 · 1,445 trades